Neo Ivy Capital Management’s Hims & Hers Health HIMS Stock Holding History

Neo Ivy Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.13M	Sell	61,531 -37,051	-38%	-$995K	0.49%	74
2026 Q1	$2.05M	Sell	98,582 -92,333	-48%	-$2.18M	0.54%	72
2025 Q4	$6.2M	Buy	190,915 +126,697	+197%	+$5.43M	0.98%	17
2025 Q3	$3.64M	Buy	64,218 +7,273	+13%	+$373K	0.89%	15
2025 Q2	$2.84M	Buy	56,945 +37,107	+187%	+$1.68M	0.91%	17
2025 Q1	$586K	Sell	19,838 -146,896	-88%	-$5.46M	0.19%	151
2024 Q4	$4.03M	Buy	166,734 +98,798	+145%	+$2.45M	0.81%	21
2024 Q3	$1.25M	Buy	+67,936	New	+$1.22M	0.41%	103

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Neo Ivy Capital Management's HIMS Position: Q2 2026 in Review

Neo Ivy Capital Management reduced its Hims & Hers Health (HIMS) stake by 38% in Q2 2026, selling an estimated $995K and leaving 61,531 shares worth $2.13M. The position accounts for 0.49% of the portfolio, ranked #74.

Neo Ivy Capital Management first reported a position in HIMS in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.2M in Q4 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Neo Ivy Capital Management held 61,531 shares of Hims & Hers Health worth $2.13M as of Q2 2026.
Neo Ivy Capital Management sold 37,051 Hims & Hers Health shares in Q2 2026, an estimated $995K.
Hims & Hers Health made up 0.49% of Neo Ivy Capital Management's portfolio in Q2 2026, its #74 holding.
Neo Ivy Capital Management first reported a position in Hims & Hers Health in Q3 2024 and has held it in 8 quarters since.
Neo Ivy Capital Management's Hims & Hers Health position peaked at $6.2M in Q4 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.